Healthcare & Life Sciences
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a Healthcare & Life Sciences startup, most recent round Series B, 2 tracked investors.
series-b
series-b
Stage
2
Investors
About Day One Biopharmaceuticals
Day One Biopharmaceuticals is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Day One Biopharmaceuticals develops new medicines targeting pediatric low-grade glioma (pLGG) and provides resources to assist families in managing diagnosis and treatment.
Explore Day One Biopharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.